Why Reuters relentlessly attacks Sinovac COVID-19 Vaccine
As of July 18, 3.6 billion doses of vaccine has been administered throughout the world. These are much needed vaccines to save lives and livelihood to ensure people are and safe and can go back to their daily routine.
From the number of vaccines administered and plenty more to be administered, it is pretty obvious, vaccine is a trillion dollar business. Sinovac, despite coming in later that Pfizer, has now surpassed as the world’s most administered vaccine for adults and elderly.
The void of children’s vaccine is the next race. Out of 7.9 billion population of the world, children below 18 are estimated to be around 25%, Pfizer- BioNTech has recently been approved for children 12-15 years of age. However, majority of countries have decided not proceed with the children vaccination due to the risk of heart inflammation experienced by earliy adopting country especially in Israel. The other vaccines approved for children are two Chinese made vaccines, one being Sinovac. Since Sinovac is based on old but proven inactivated virus technology and used in many other vaccines for children inoculation, Phase 2 trials have shown the effectiveness without any major side-effects. It has been approved safe for children 3 to 17 years of age and administered throughout China.
Now comes the dirty play.
Western press are known to be very biased. The colonial mindset is not dead and the East must succumb and bow to the West. Business of the East cannot be any larger or superior than the West. We have seen this in Huawei vs the West, palm oil vs corn oil, basis of US-Sino trade war and many other discriminative policies.
Why does West have so much power to influence and East fails?
The answer lies on the media. Almost all media barons are connected to corporate.
Reuters has been making many negative accusation to the Chinese vaccine especially Sinovac since it became the top administered vaccine of the world. What did Sinovac do to trigger such a spin from Reuters?
The answer lies in the association. James C. Smith who is heading Reuters sits in Pfizer board. Whala, there you go.
Let’s see few of the negative spins they have done recently to attack Sinovac:
1. Fake news: Sinovac has a very low afficacy
Butatan institute did an independent Clinical Tral (Sinovac has no say on the study) for healthcare workers during the peak of the pandemic in Brazil. Despite the exposure of healthcare workers, Sinovac achieved 100% protection against death and majority were in very mild category. Pfizer on the other hand had full control of the trial, did their study in US end 2020 during the low cases, covered majority general public and the number does to cover very mild cases. Batter result study in Turkey for general public did not make major headlines.
2. Fake news: Sinovac is not effective against Delta
On 21 June 2021, in a report titled ‘Sinovac Vaccine Protects Health Workers From Severe Covid-19 in Delta-Hit Kudus’ by Jakarta Globe, Indonesia reported 308 of their healthcare workers vaccinated contracted COVID-19 predominantly by Delta variant. 7.1% were hospitalized while the rest were on self-quarantine. There were ZERO death. Sinovac has proven in real-life statistic, it is fully effective in preventing death and reduce strain on healthcare system for need of hospitalization.
On the other hand, the same day Reuter’s article pick by CNN titles itself ‘Hundreds of vaccinated Indonesian health workers get Covid-19, dozens in hospital’.
There are long list of injustice toward Sinovac who is seen as a threat to the trillion dollar industry that the West believes is their God given right.
Government of the world should not succumb to such propaganda and should focus in the interest of their citizens.
Only vaccine in arm can protect against COVID-19 and governments must get any WHO approved vaccines as fast as possible to vaccinate. Be it coming from the West or the East.